Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study
BRIM-55
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible. The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study. Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedStudy Start
First participant enrolled
August 24, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
Study Completion
Last participant's last visit for all outcomes
June 30, 2027
July 16, 2026
July 1, 2026
5 months
July 2, 2026
July 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Recruitment
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. Green: ≥8% of the invited population starting intervention. Yellow: \<8% and ≥6%. Red: \<6%.
Six weeks from when the invitation letter was sent out
Acceptability
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. Green: ≥75% of eligible participants consent. Yellow: \<75% and ≥60%. Red: \<60%.
Four weeks from the screening interview
Participant adherence
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. Green: ≥70% of the participants completing a minimum of 4 sessions with the therapist. Yellow:\<70% and ≥60%. Red: \<60%
From start of intervention to 12 weeks later.
Retention
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. Green: ≥90% complete data on the CDI, post-treatment. Yellow: \<90% and ≥75%. Red: \<75%.
From the end of the intervention to two weeks later.
Adverse events
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. Green: no inconveniences or adverse events linked to study participation reported. Yellow: ≤ 2 reports of inconveniences (comparable to max 2 days of increased fatigue, stress or worry). Red: any adverse event or more than 3 inconveniences reported linked to study participation
From intervention start to four weeks after intervention end.
Program credibility
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The credibility subscale of the Credibility and Expectancy Questionnaire has a max score of 27. A higher score means more credibility. Green: ≥75% of participants rate the credibility subscale of CEQ ≥ 7. Yellow: ≥75% rate it \< 7 and ≥ 5. Red: \>25% rate it \< 5.
Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.
Program satisfaction
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The Client Satisfaction Questionnaire 8 items version (CSQ-8) has a max score of 32 where a higher score means more satisfaction. Green: ≥ 75% of participants score ≥26 on the CSQ-8. Yellow: ≥ 75% rate it ≥24. Red: \> 25% rate it \<24.
From the end of the intervention to two weeks later.
Other Outcomes (7)
Cardiac distress
Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Recovery Experience
Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
Health-related quality of life
From the end of the intervention to two weeks later.
- +4 more other outcomes
Study Arms (1)
Remote-delivery Balance in Everyday Life (rBEL) intervention group
EXPERIMENTALParticipants randomized to this arm will receive the Remote-delivery Balance in Everyday Life (rBEL) program, a therapist-supported behavioral stress recovery intervention delivered over 12 weeks. The program includes six individual online sessions, a printed workbook containing exercises and self-monitoring materials, and access to online video resources. The intervention is designed to promote recovery behaviors, improve stress regulation, and reduce cardiac distress following myocardial infarction.
Interventions
The Remote-delivery Balance in Everyday Life (rBEL) program is a 13-week therapist-supported behavioral stress recovery intervention for adults younger than 55 years who have experienced a myocardial infarction and report cardiac distress. The program includes six individual online sessions delivered by a therapist, a printed exercise workbook, and online video materials. The content focuses on recovery behaviors, relaxation training, self-monitoring, use of recovery strategies in daily life and work settings, and management of heart-related worry and anxiety.
Eligibility Criteria
You may qualify if:
- Myocardial infarction (MI) before age 55 years
- MI within one year prior to randomization
- Report of subjective cardiac distress in the initial interview
You may not qualify if:
- Serious conditions hindering participation (e.g., active substance misuse, severe mental illness)
- Insufficient Swedish proficiency for study procedures,
- Disability pension or early retirement at the time of MI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uppsala University
Uppsala, 752 37, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erik Olsson MG Olsson, Professor
Uppsala University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 2, 2026
First Posted
July 16, 2026
Study Start (Estimated)
August 24, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Due to the European data protection law, this will not be allowed without a special ethical approval.